Fresenius Kabi Oncology Ltd. - Research Center
FKONCO Group (B) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Dec' 13 |
Sep' 13 |
Jun' 13 |
Mar' 13 |
Dec' 12 |
Sales |
84.66 |
96.15 |
126.87 |
93.24 |
205.04 |
Operating profit |
-36.72 |
-28.88 |
8.48 |
11.35 |
61.31 |
Interest |
9.94 |
7.32 |
-4.68 |
-2.07 |
-7.73 |
Gross profit |
-40.46 |
-36.20 |
14.01 |
14.24 |
69.03 |
EPS (Rs) |
-4.02 |
-2.83 |
0.30 |
-0.49 |
3.06 |
Quarterly
results in details
|
Dec' 13 |
Sep' 13 |
Jun' 13 |
Mar' 13 |
Dec' 12 |
Other income |
6.20 |
- |
0.86 |
0.82 |
- |
Stock adjustment |
-25.72 |
-7.67 |
1.15 |
-34.52 |
18.83 |
Raw material |
53.88 |
35.05 |
35.59 |
51.55 |
29.05 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
20.29 |
20.37 |
15.21 |
17.41 |
17.16 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
34.92 |
12.20 |
37.84 |
9.26 |
47.95 |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
38.01 |
65.08 |
28.60 |
38.19 |
30.75 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
8.34 |
7.53 |
6.91 |
6.53 |
6.69 |
Taxation |
2.38 |
1.06 |
2.31 |
8.66 |
13.99 |
Net profit / loss |
-63.63 |
-44.79 |
4.80 |
-7.76 |
48.36 |
Extra ordinary item |
-12.44 |
- |
- |
-6.81 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
15.82 |
15.82 |
15.82 |
15.82 |
15.82 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
131.51 |
300.63 |
300.63 |
300.63 |
300.63 |
Agg.of non promotoholding (%) |
8.31 |
19.00 |
19.00 |
19.00 |
19.00 |
OPM (%) |
-43.38 |
-30.04 |
6.69 |
12.18 |
29.90 |
GPM (%) |
-44.53 |
-37.64 |
10.97 |
15.14 |
- |
NPM (%) |
-70.03 |
-46.59 |
3.76 |
-8.25 |
- |